Initial $175 Million Close Of Our Fund V (Target Of $250–275 Million For The Final Close)

We are pleased to announce the initial closing of our new flagship fund, Blume Ventures Fund V, at USD 175 million. Fund V is on track for a final close of USD 250 – 275 million by early 2026.

We have secured continued support from our existing marquee investors while welcoming new institutional investors, multilateral institutions, corporates, and family offices.

Fund V coincides with our 15^th anniversary, marking a significant milestone in our journey of supporting visionary founders who address large-scale challenges and build for both Indian and international markets. Fund V will continue our proven strategy of investing in early-stage Indian and cross-border ventures and has already begun deploying capital with initial investments across Health-tech (Mave Health), B2B AI (Confido Health), Consumer (Lucira and Ozi), Fin-tech (PowerUp Money), and Deep-tech (iDO).

2025 has emerged as a pivotal year for Blume, with substantial momentum in exits and distributions to Limited Partners across Fund I and II vintages. Fund III and IV portfolios have demonstrated strong growth, with the firm anticipating an aggregate DPI of over USD 80 million across all funds in 2025. The firm’s IPO pipeline is set to launch, beginning with Turtlemint, which has filed the DRHP with regulators.